These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7785490)

  • 41. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
    Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
    Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibiting protein-protein interactions: a model for antagonist design.
    Chrunyk BA; Rosner MH; Cong Y; McColl AS; Otterness IG; Daumy GO
    Biochemistry; 2000 Jun; 39(24):7092-9. PubMed ID: 10852706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of potent human anti-IL-1RI antagonist antibodies.
    Fredericks ZL; Forte C; Capuano IV; Zhou H; Vanden Bos T; Carter P
    Protein Eng Des Sel; 2004 Jan; 17(1):95-106. PubMed ID: 14985542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.
    Kilian PL; Kaffka KL; Stern AS; Woehle D; Benjamin WR; Dechiara TM; Gubler U; Farrar JJ; Mizel SB; Lomedico PT
    J Immunol; 1986 Jun; 136(12):4509-14. PubMed ID: 2940296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
    Schreuder H; Tardif C; Trump-Kallmeyer S; Soffientini A; Sarubbi E; Akeson A; Bowlin T; Yanofsky S; Barrett RW
    Nature; 1997 Mar; 386(6621):194-200. PubMed ID: 9062194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.
    Li S; Neff CP; Barber K; Hong J; Luo Y; Azam T; Palmer BE; Fujita M; Garlanda C; Mantovani A; Kim S; Dinarello CA
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2497-502. PubMed ID: 25654981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Function, molecular structure and gene expression of interleukin-1].
    Kasahara T; Kuno K; Matsushima K
    Nihon Rinsho; 1992 Aug; 50(8):1769-75. PubMed ID: 1433966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conformational dynamics and kinetics of peptide antagonist interactions with interleukin-1 receptor. Fluorescence studies using the NBD-labelled peptide AF12415.
    Cowley DJ; Schulze AJ
    J Pept Res; 1997 May; 49(5):444-54. PubMed ID: 9211226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modularity of protein function: chimeric interleukin 1 beta s containing specific protease inhibitor loops retain function of both molecules.
    Wolfson AJ; Kanaoka M; Lau F; Ringe D; Young P; Lee J; Blumenthal J
    Biochemistry; 1993 May; 32(20):5327-31. PubMed ID: 8499437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modelling of fish interleukin-1 and its receptor.
    Scapigliati G; Costantini S; Colonna G; Facchiano A; Buonocore F; Bossù P; Cunningham C; Holland JW; Secombes CJ
    Dev Comp Immunol; 2004 May; 28(5):429-41. PubMed ID: 15062642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of regions in interleukin-1 alpha important for activity.
    Gayle RB; Poindexter K; Cosman D; Dower SK; Gillis S; Hopp T; Jerzy R; Kronheim S; Lum V; Lewis A
    J Biol Chem; 1993 Oct; 268(29):22105-11. PubMed ID: 8408069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluorescence and site-directed mutagenesis studies of interleukin 1 beta.
    Epps DE; Yem AW; McGee JM; Tomich CS; Curry KA; Chosay JG; Deibel MR
    Cytokine; 1997 Mar; 9(3):149-56. PubMed ID: 9126703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-range coupling between separate docking sites in interleukin-1beta.
    Heidary DK; Roy M; Daumy GO; Cong Y; Jennings PA
    J Mol Biol; 2005 Nov; 353(5):1187-98. PubMed ID: 16216268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure of an interleukin-1 beta mutant with reduced bioactivity shows multiple subtle changes in conformation that affect protein-protein recognition.
    Camacho NP; Smith DR; Goldman A; Schneider B; Green D; Young PR; Berman HM
    Biochemistry; 1993 Aug; 32(34):8749-57. PubMed ID: 8364024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Species differences in [125I]interleukin-1 binding in brain, endocrine and immune tissues.
    Takao T; Newton RC; De Souza EB
    Brain Res; 1993 Sep; 623(1):172-6. PubMed ID: 8221088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of IL-1 activity by soluble IL-1 receptors.
    Kurrle R; Lauffer L; Röder J; Kanzy EJ; Enssle KH; Seiler FR
    Behring Inst Mitt; 1995 Jun; (96):45-57. PubMed ID: 7575352
    [No Abstract]   [Full Text] [Related]  

  • 57. Monotonicity of interleukin-1 receptor-ligand binding with respect to antagonist in the presence of decoy receptor.
    Gnacadja G; Shoshitaishvili A; Gresser MJ; Varnum B; Balaban D; Durst M; Vezina C; Li Y
    J Theor Biol; 2007 Feb; 244(3):478-88. PubMed ID: 17011587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a biologically functional novel IL-1 beta-specific receptor on adult rat hepatocytes.
    Kohira T; Matsumoto K; Ichihara A; Nakamura T
    J Biochem; 1993 Nov; 114(5):658-62. PubMed ID: 8113217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of IL-1 receptor accessory protein on IL-1 binding.
    Wesche H; Resch K; Martin MU
    FEBS Lett; 1998 Jun; 429(3):303-6. PubMed ID: 9662437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on IL-1 receptors on D10S T-helper cells: demonstration of two molecularly and antigenically distinct IL-1 binding proteins.
    Savage N; Puren AJ; Orencole SF; Ikejima T; Clark BD; Dinarello CA
    Cytokine; 1989 Nov; 1(1):23-35. PubMed ID: 2535251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.